Notice: The information provided by Li Ka Shing Faculty of Medicine, The University of Hong Kong (“HKU”) on URL: scan2030.hku.hk (the “SCAN2030 Website”) is: (a) technical in nature, which has a technical character regarding medical and health economics and outcomes research as well as health technology assessment; (b) only intended for: (i) facilitating research and development in relation to medical and healthcare related policies; and (ii) medical and healthcare researchers, policy makers and/or stakeholders, including medical practitioners, pharmacists, medical and para-medical staff of public / private hospitals (the “Target Users”). All information on the SCAN2030 Website is provided in good faith. However, HKU makes no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability, or completeness of any information on the SCAN2030 Website.
Would you like to visit our SCAN2030 website?
由港大醫學院教授李雪帶領的全港首個抑鬱症健康經濟模型研究顯示,香港於2023年至2032年將持續面臨診治抑鬱症的重大負擔。研究團隊利用來自醫管局的全港電子病歷,聚焦2014年至2016年間診斷為抑鬱症的25,190名患者,並進行為期7年的隨訪直至2020年。研究預測,由2023至2032年,香港每年將有55,849至57,896名患者罹患抑鬱症,帶來的年均醫療成本超過25.1億港元,其中精神科的護理成本開支為4.735億港元。閱讀全文:http://bit.ly/40C07YJ